Total Funding
19
36
Total FundingConvertible Note raised
Growth Score
-6 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
91599
Radiance Therapeutics is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery.
- Laurence J. Marsteller: CEO & Co-FounderPast Role: Salutaris Medical Devices, Lead Co-Founder & Co-Innovator
John Wollman: InvestorPast Role: HighPoint Solutions, EVP & Chief Innovation Officer
About the Company
Radiance Therapeutics is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery.
The company was founded in 2018 and is headquartered in Tucson, Arizona.
